Company Info
Phone(617) 274-4000
Year Established
1980
Ticker
SRPT
Exchange
NASDAQ
Contacts
Douglas S. IngramPresident & CEO
Dallan Murray
CCO
Ian Estepan
CFO
Louise Rodino-Klapac, Ph.D.
CSO
Ryan Brown
General Counsel
Bilal Arif Bilal Arif
CTO
Will Tilton Will Tilton
Head of Strategy, Chief of Staff
Company Description
Sarepta, formerly AVI BioPharma, has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development.
